Xu, Y., Su, P., Li, Z., Wang, M., Wen, S., Zhang, Y., Zhu, Y., Qi, J., Sun, B., Gao, W., Wang, H., Ma, Y., Su, C., Wu, T., Tian, Z. (2026). Neoadjuvant tislelizumab plus oxaliplatin and S-1 for locally advanced Siewert type II esophagogastric junction adenocarcinoma: A prospective multicenter phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4091